1. Home
  2. CLLS vs BCBP Comparison

CLLS vs BCBP Comparison

Compare CLLS & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • BCBP
  • Stock Information
  • Founded
  • CLLS 1999
  • BCBP 2000
  • Country
  • CLLS France
  • BCBP United States
  • Employees
  • CLLS N/A
  • BCBP N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • BCBP Savings Institutions
  • Sector
  • CLLS Health Care
  • BCBP Finance
  • Exchange
  • CLLS Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • CLLS 240.2M
  • BCBP 201.8M
  • IPO Year
  • CLLS 2007
  • BCBP N/A
  • Fundamental
  • Price
  • CLLS $1.87
  • BCBP $13.27
  • Analyst Decision
  • CLLS Buy
  • BCBP Hold
  • Analyst Count
  • CLLS 3
  • BCBP 2
  • Target Price
  • CLLS $7.00
  • BCBP $13.75
  • AVG Volume (30 Days)
  • CLLS 93.0K
  • BCBP 42.3K
  • Earning Date
  • CLLS 11-04-2024
  • BCBP 10-18-2024
  • Dividend Yield
  • CLLS N/A
  • BCBP 4.82%
  • EPS Growth
  • CLLS N/A
  • BCBP N/A
  • EPS
  • CLLS N/A
  • BCBP 1.17
  • Revenue
  • CLLS $36,042,000.00
  • BCBP $89,636,000.00
  • Revenue This Year
  • CLLS $271.02
  • BCBP N/A
  • Revenue Next Year
  • CLLS $33.48
  • BCBP $6.99
  • P/E Ratio
  • CLLS N/A
  • BCBP $11.35
  • Revenue Growth
  • CLLS 46.96
  • BCBP N/A
  • 52 Week Low
  • CLLS $1.70
  • BCBP $9.19
  • 52 Week High
  • CLLS $3.77
  • BCBP $13.90
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 47.58
  • BCBP 63.25
  • Support Level
  • CLLS $1.70
  • BCBP $13.15
  • Resistance Level
  • CLLS $2.00
  • BCBP $13.65
  • Average True Range (ATR)
  • CLLS 0.11
  • BCBP 0.29
  • MACD
  • CLLS 0.02
  • BCBP 0.11
  • Stochastic Oscillator
  • CLLS 56.67
  • BCBP 79.57

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.

Share on Social Networks: